Immix Biopharma Inc (IMMX) — Financial Flexibility Index
Immix Biopharma Inc (IMMX) has a Financial Flexibility Index of -0.86x as of March 2026. Free cash flow of $-9.79 Million (operating CF $-9.83 Million minus capex $32.49K) represents -1% of total liabilities ($11.45 Million). Check Immix Biopharma Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Immix Biopharma Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Immix Biopharma Inc across 7 annual periods. See IMMX current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Immix Biopharma Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Immix Biopharma Inc. For the full company profile including market capitalisation, see IMMX company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.10x | $-23.20 Million | $-23.93 Million | $11.04 Million | ▼ -51.8% |
| 2024 | -1.38x | $-13.42 Million | $-14.60 Million | $9.70 Million | ▲ +54.5% |
| 2023 | -3.04x | $-11.32 Million | $-11.37 Million | $3.72 Million | ▲ +28.2% |
| 2022 | -4.24x | $-7.41 Million | $-7.41 Million | $1.75 Million | ▲ +46.1% |
| 2021 | -7.86x | $-1.59 Million | $-1.59 Million | $202.04K | ▼ -10139.0% |
| 2020 | -0.08x | $-404.69K | $-404.69K | $5.27 Million | ▲ +55.0% |
| 2019 | -0.17x | $-782.72K | $-790.03K | $4.59 Million | — |